Page results
-
UCLH patient information for using Control IQ technology
-
UCLH Learning Disabilities and Autism Team Telephone: 020 3447 8238 Email: uclh.referrals.learning.disabilities@nhs.net…
-
This page will give you an overview of intravesical thermo-chemotherapy, how it is given and side effects it may cause.
-
This page will give you an overview of intravesical chemotherapy, how it is given and side effects it may cause.
-
This page will give you an overview of intravesical RF induced thermochemotherapy, how it is given and side effects it may cause.
-
The following information has been written by the Specialist Physiotherapist who works for the Mitochondrial service. The page provides information about activity and exercise for people living with…
-
Benefits of exercise Improve aerobic conditioning (physical activity endurance). Improve efficiency in getting into the second wind. Prevent muscle weakness due to inactivity. Control…
-
This page will give you an overview of intravesical chemotherapy, how it is given and side effects it may cause.
-
This booklet has been written by tracheostomy team at The National Hospital for Neurology and Neurosurgery. It is intended to provide information for patients (or their families and carers) about…
File results
-
FOI/2024/0598 - Agency arrangement/ agreement supplier list for provision of AHPs, doctors and nursing
-
FOI/2024/0607 - Starvation ketoacidosis patients/ treatment
-
FOI/2024/0551 - Trust's total planned CIP/ efficiency savings for 2024/25
-
FOI/2024/0618 - Cyber security team contact details
-
FOI/2024/0620 - Women/ birthing people diverted to other NHS trusts in 2024
-
FOI/2024/0623 - Patient numbers sent to use MRI scanner at London Zoo from 2014-2024
-
FOI/2024/0628 - Service personnel/ armed force families access to speech and language therapy for children who stammer
-
FOI/2024/0633 - Adults, children diagnosed/ living with Glycogen storage disease type V (Mcardle's disease)
-
FOI/2024/0635 - Patient incidences/ injuries due to chiropractic treatment
-
FOI/2024/0648 - Performance management Policy for July 2020 to November 2022